Azenta Inc.
Rating
Updated: Aug 26, 2026Key Statistics
Market Data
Valuation (TTM)
Valuation (NTM)
Cash Flow
Margins
Growth (CAGR)
Returns
Financial Health
Dividends
Profile
Azenta, Inc. is a global leader specializing in advanced solutions for the discovery, handling, and preservation of life science samples. The company's operations span across North America, Europe, As...
Latest News
5 days ago · prnewswire.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Azenta, Inc. - AZTANEW YORK, Sept. 17, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Azenta, Inc. ("Azenta" or the "Company") (NASDAQ: AZTA).
18 days ago · prnewswire.com
Azenta Receives Full Repayment of $35 Million Vendor Loan Related to Sale of B Medical SystemsBURLINGTON, Mass., Sept. 4, 2026 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that it has received repayment in full, prior to maturity, of the $35 million secured vendor loan extended in connection with the previously announced sale of B Medical Systems S.
29 days ago · prnewswire.com
AZENTA ANNOUNCES LEADERSHIP TRANSITIONCurrent Director Dr. Martin Madaus Appointed Interim CEO Company Reaffirms Previously Announced Fourth Quarter Fiscal 2026 Total Revenue Guidance BURLINGTON, Mass., Aug. 24, 2026 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) ("Azenta" or "the Company") today announced that current member of the Board of Directors (the "Board") Dr. Martin Madaus has been appointed interim President and CEO, and that John Marotta has resigned as an executive officer and director of the Company.
1 month ago · seekingalpha.com
Azenta: Needs To Overcome A Few Hurdles If The Rally Is To ContinueAZTA went down for a long time, resulting in a multi-year low in May 2026, but the stock has rallied higher since then. While the stock has doubled in value, there is a chart that suggests to be wary of the rally because it could unwind itself in the near future. The current financial model from AZTA makes a case for being long, but that depends on whether AZTA can hit the targets laid out.
2 months ago · seekingalpha.com
Azenta, Inc. (AZTA) Q3 2026 Earnings Call TranscriptAzenta, Inc. (AZTA) Q3 2026 Earnings Call Transcript
2 months ago · marketbeat.com
Azenta Q3 Earnings Call HighlightsAzenta NASDAQ: AZTA reported third-quarter fiscal 2026 revenue that exceeded its outlook, as growth in recurring-revenue businesses and improved Multiomics performance helped offset continued unevenness in capital equipment markets.
2 months ago · prnewswire.com
Azenta Reports Third Quarter Results for Fiscal 2026, Ended June 30, 2026.BURLINGTON, Mass., Aug. 4, 2026 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today reported financial results for the third quarter ended June 30, 2026.
2 months ago · prnewswire.com
Azenta Announces Fiscal 2026 Third Quarter Conference Call and WebcastBURLINGTON, Mass., July 22, 2026 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) will announce fiscal third quarter 2026 earnings which ended on June 30, 2026, on Tuesday, August 4, 2026, after the market closes.
3 months ago · prnewswire.com
Azenta Completes Sale of B Medical SystemsBURLINGTON, Mass., July 8, 2026 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced the completion of the previously disclosed sale of its B Medical Systems business to Thelema S.
4 months ago · gurufocus.com
Azenta Inc (AZTA) Stock Up 5.4% and Still Undervalued -- GF Score: 72/100On May 28, 2026, Azenta Inc (AZTA) shares rose 5.4%, bringing the current price to $22.49. The stock has experienced considerable volatility, with a 52-week ran
Analyst Summary
Add to Watchlist
Select watchlists to add or remove AZTA